Surufatinib: First Approval
This article summarizes the milestones in the development of surufatinib leading to this first approval for extrapancreatic NET.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | China Health | Drugs & Pharmacology | Neurology | Oral Cancer | Pancreas | Pancreatic Cancer | Sarcomas | Soft Tissue Sarcoma | Thyroid | Thyroid Cancer